Krishna Tangirala

Krishna Tangirala has extensive experience in the field of Health Economics and Outcomes Research (HEOR). Krishna is currently serving as the Director and Head of Outcomes Research Data Analytics at Organon since September 2021. Prior to this, they held various positions at different pharmaceutical companies including Teva Pharmaceuticals, Bayer Pharmaceuticals, Otsuka Pharmaceutical Companies (U.S.), sanofi-aventis, and Eli Lilly. In these roles, they were responsible for developing and executing research strategies, conducting pharmacoeconomics and health outcomes research projects, managing product portfolios, and leading communication and dissemination of outcome research studies. Krishna also worked as an epidemiologist at the Indiana State Department of Health and held a visiting research associate position at Indiana University. Overall, they have a strong background and expertise in HEOR and has contributed significantly to the field throughout their career.

Krishna Tangirala completed their Executive MBA in Business Administration and Management from Rutgers Business School from 2023 to 2025. Prior to that, they pursued a Master of Public Health (MPH) with a focus on Epidemiology and Biostatistics from Indiana University Bloomington between 2002 and 2004. Krishna's undergraduate education took place at NTR University of Health Sciences from 1995 to 2001, although the specific degree earned is unknown in the provided information.

Additionally, Krishna Tangirala obtained several certifications related to SAS Viya, including "SAS Visual Analytics 2 for SAS Viya: Advanced" in May 2023, "SAS Visual Analytics 1 for SAS Viya: Basics" in April 2023, and "SAS Viya Overview" in October 2022.